Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
NRSN stock price ended at $0 on Friday, after dropping NaN%
On the latest trading day May 01, 2026, the stock price of NRSN fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for NRSN decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
NRSN Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
NRSN currently exhibits 0 buy signals and 0 sell signals. The stock has been in an downtrend since --, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for NRSN
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for NRSN. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to NRSN?
According to technical analysis, Neurosense Therapeutics Ltd has an aggregate signal of Neutral. Neurosense Therapeutics Ltd has 0 Buy signals, 7 Neutral Signals and 0 sell signals.
What is the RSI for Neurosense Therapeutics Ltd?
The RSI for Neurosense Therapeutics Ltd is currently 0, indicating a neutral condition
What is Neurosense Therapeutics Ltd price for the next 12 months?
Neurosense Therapeutics Ltd NRSN price for the next 12 months is estimated at $0.
How high is Neurosense Therapeutics Ltd expected to go?
According to wall street analysts, Neurosense Therapeutics Ltd is expected to reach a high forecast of $0.